Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

InsideArbitrage Potential Deal Alert: GreenLight Biosciences (GRNA) approached by Fall Line

  • March 30, 2023


StockGreenLight Biosciences HoldingsSymbolGRNA
Date Announced03/30/2023Source Press Release
TypeUnsolicited BidAcquiring Company/Person Fall Line Capital, LLC
Date of Confirmation: 05/30/2023Price at Confirmation: $0.20
Potential Profit: -53.49%Annualized Profit: -320.05%

GreenLight Biosciences (GRNA) confirmed that it has received a non-binding indication of interest from Fall Line Endurance Fund, L.P. to acquire all of the outstanding capital stock of the Company for $0.60 per share in cash.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.